Dr. Faubion is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13400 E Shea Blvd
Scottsdale, AZ 85259Phone+1 480-301-8000
Summary
- I am a board certified pediatric and adult gastroenterologist specializing in Inflammatory Bowel Disease. I have over 15 years experience in translational research, mucosal immunology, clinical trials, and the clinical management as it relates to these diseases.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1998 - 2000
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pediatric Gastroenterology, 1996 - 1998
- University of Texas Health Science Center at HoustonResidency, Internal Medicine/Pediatrics, 1992 - 1996
- McGovern Medical School at UTHealthClass of 1992
Certifications & Licensure
- AZ State Medical License 2023 - 2026
- MN State Medical License 1996 - 2025
- FL State Medical License 2013 - 2019
- TX State Medical License 1993 - 2007
- American Board of Internal Medicine Gastroenterology
- American Board of Pediatrics Pediatric Gastroenterology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry Start of enrollment: 2002 Jan 28
- Stem Cell Fistula Plug in Perianal Crohn's Disease Start of enrollment: 2013 Jul 01
- Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis Start of enrollment: 2014 Dec 12
- Join now to see all
Publications & Presentations
PubMed
- 27 citationsRegulation and Role of αE Integrin and Gut Homing Integrins in Migration and Retention of Intestinal Lymphocytes during Inflammatory Bowel Disease.Mary E. Keir, Franklin Fuh, Ryan Ichikawa, Meghan Acres, Jason A. Hackney
Journal of Immunology. 2021-09-24 - 399 citationsClinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel DiseaseWaqqas Afif, Edward V. Loftus, William A. Faubion, Sunanda V. Kane, David H. Bruining
The American Journal of Gastroenterology. 2010-05-01 - 128 citationsAutologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's DiseaseAllan B. Dietz, Eric J. Dozois, Joel G. Fletcher, Greg W. Butler, Darcie J. Radel
Gastroenterology. 2017-07-01
Press Mentions
- Ulcerative Colitis Mucosal Transcriptomes Reveal Mitochondriopathy and Personalized Mechanisms Underlying Disease Severity and Treatment ResponseJanuary 3rd, 2019
- Stem Cell Fistula Plug in Post Surgical Leak FistulasSeptember 28th, 2016
Grant Support
- KLF10 Regulates Colitis Through Mediating TGFB Induction Of FOXP3 In Treg CELLS.National Institute Of Allergy And Infectious Diseases2011–2012
- KLF10 Regulates Colitis Through Mediating TGFB Induction Of FOXP3 In Treg CELLS.National Institute Of Allergy And Infectious Diseases2010
- Role Of The Co-Stimulator Molecular SLAM In ColitisNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2007
- Role Of The Co-Stimulator Molecular SLAM In ColitisNational Institute Of Diabetes And Digestive And Kidney Diseases2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: